|
National Prostate
Cancer Prevention Trial sponsored by Southwest Oncology Group (SWOG)
BULLETIN: SELECT TRIAL IS NOW CLOSED TO ENROLLMENT, WITH 35,534 MEN ENROLLED IN THE STUDY NATIONALLY.
UPDATE: TRIAL PARTICIPANTS ARE ADVISED TO DISCONTINUE THEIR SUPPLEMENTS, NOTING THE FOLLOWING:
On September 15, 2008 the independent Data and Safety Monitoring Committee (DSMC) met and recommended that participants stop taking their Study Supplements because the evidence to date convincingly demonstrated no benefit from either agent. Investigators from the study leadership and the National Cancer Institute have also reviewed the findings and agree with these recommendations.
Although the Study Supplements are being stopped, the trial and follow-up will continue.
To view a press release from the National Institutes of Health, click here on News Release.
KEEP AN EYE ON THIS SITE FOR FURTHER UPDATES.
FOR MORE INFORMATION:
ContactPrevention Director Bernadette Bensman, RN,
BS
at (937) 395-8678 or by E-Mail at bernadette.bensman@wright.edu
Information
is also available on the SELECT web site at
SWOG
|
